| payload |
{"created_at":"2026-04-11T03:10:51.104 {"created_at":"2026-04-11T03:10:51.104915+00:00","dedupe_key":"signal_enriched:discovery_sec_filing_delta:546e616177c399da","evidence_event_ids":["evt_b8ab9c5f5096"],"signal_type":"discovery_sec_filing_delta","source":"discovery_sec_filings","value":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1635088/0001140361-26-014301.txt","as_of":"2026-04-11T03:10:51.104915+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1635088/0001140361-26-014301.txt","company":"Roivant Sciences Ltd.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1635088/0001140361-26-014301.txt","article_chars":1990,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_11308b261f9994d8","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1635088/0001140361-26-014301.txt","content_type":"text/plain","enriched_at":"2026-04-11T09:06:19.408239+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1635088/0001140361-26-014301.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1635088/0001140361-26-014301.txt","source_event_id":"evt_b8ab9c5f5096","source_quality":"medium","status_code":200,"version":"signal_enrichment_v2"},"form_type":"4","fp":"f8e0c9bd86ecb215","kind":"sec_filing","published_at":"20260410","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.78,"dates_mentioned":["2026-04-10","2026-04-08"],"entities":[{"asset_class":"equity","name":"Roivant Sciences Ltd.","relevance":"high","symbol":"ROIV","type":"issuer"},{"asset_class":"equity","name":"Jennifer Humes","relevance":"high","symbol":"","type":"reporting_person"},{"asset_class":"equity","name":"Common Shares","relevance":"high","symbol":"","type":"security"}],"event_type":"listing","information_gaps":["What changed vs prior known state is not provided in the signal; only the existence/content of this Form 4 is shown.","The filing text excerpt does not explicitly state whether the transaction was a sale vs other action beyond the described price/undertaking language; however the excerpt indicates shares were sold.","No prior holdings/balance before/after the transaction are included in the provided text excerpt.","No total proceeds or remaining ownership figures are present in the provided text excerpt."],"key_facts":["SEC filing is Form 4 (SEC Act 1934) for Roivant Sciences Ltd.","Filed as of date: 2026-04-10; conform ed period of report: 2026-04-08.","Reporting person: Jennifer Humes (identified as Chief Accounting Officer).","Security: Common Shares.","Transaction date shown: 2026-04-08.","Quantity: 13,538 common shares.","Price: weighted average price of $28.37 (reported in column 4).","Shares were sold in multiple transactions at prices ranging from $28.36 to $28.38, inclusive.","Filing includes an undertaking to provide full information on number of shares sold at each separate price within the range upon request."],"numeric_claims":[{"label":"shares_sold","value":"13538"},{"label":"weighted_average_price_usd","value":"28.37"},{"label":"price_range_low_usd","value":"28.36"},{"label":"price_range_high_usd","value":"28.38"}],"primary_claim":"Form 4 for Roivant Sciences Ltd. (ROIV) was filed on 2026-04-10 by reporting person Jennifer Humes, reporting the sale of 13,538 common shares on 2026-04-08 at a weighted average price of $28.37 (range $28.36\u2013$28.38).","relevance_score":0.55,"sentiment":"neutral","source_quality":"medium","summary":"Roivant Sciences Ltd. (ROIV) filed a Form 4 on 2026-04-10 covering a transaction by reporting person Jennifer Humes (Chief Accounting Officer). The filing indicates 13,538 common shares were sold on 2026-04-08 at a weighted average price of $28.37 (range $28.36\u2013$28.38).","topics":["SEC Form 4","insider transaction","common shares sale","weighted average price","reporting person"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 4 \u00b7 Roivant Sciences Ltd. \u00b7 Filed 20260410","ticker":"ROIV","tickers":["ROIV"],"title":"ROIV filed 4","url":"https://www.sec.gov/Archives/edgar/data/1635088/0001140361-26-014301.txt"}}... |